This image shows a collection of vaccinating nanoparticles, which at their largest are about 1,000 times smaller than a human hair. The inset graphic is a representation of how the engineered proteins decorate a nanoparticle’s surface.
Immunizations could be administered within minutes where and when a disease is breaking out.
Vaccines combat diseases and protect populations from outbreaks, but the life-saving technology leaves room for improvement. Vaccines usually are made en masse in centralized locations far removed from where they will be used. They are expensive to ship and keep refrigerated and they tend to have short shelf lives.
University of Washington engineers hope a new type of vaccine they have shown to work in mice will one day make it cheaper and easy to manufacture on-demand vaccines for humans. Immunizations could be administered within minutes where and when a disease is breaking out.
“We’re really excited about this technology because it makes it possible to produce a vaccine on the spot. For instance, a field doctor could see the beginnings of an epidemic, make vaccine doses right away, and blanket vaccinate the entire population in the affected area to prevent the spread of an epidemic,” said François Baneyx, a UW professor of chemical engineering and lead author of a recent paper published online in the journal Nanomedicine.
The research was funded by a Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation and the National Institutes of Health.
In typical vaccines, weakened pathogens or proteins found on the surface of microbes and viruses are injected into the body along with compounds called adjuvants to prepare a person’s immune system to fight a particular disease. But standard formulations don’t always work, and the field is seeking ways to manufacture vaccines quicker, cheaper and tailored to specific infectious agents, Baneyx said.
The UW team injected mice with nanoparticles synthesized using an engineered protein that both mimics the effect of an infection and binds to calcium phosphate, the inorganic compound found in teeth and bones. After eight months, mice that contracted the disease made threefold the number of protective “killer” T-cells – a sign of a long-lasting immune response – compared with mice that had received the protein but no calcium phosphate nanoparticles.
The nanoparticles appear to work by ferrying the protein to the lymph nodes where they have a higher chance of meeting dendritic cells, a type of immune cell that is scarce in the skin and muscles, but plays a key role in activating strong immune responses.
In a real-life scenario, genetically engineered proteins based on those displayed at the surface of pathogens would be freeze-dried or dehydrated and mixed with water, calcium and phosphate to make the nanoparticles. This should work with many different diseases and be especially useful for viral infections that are hard to vaccinate against, Baneyx said.
He cautioned, however, that it has only been proven in mice, and the development of vaccines using this method hasn’t begun for humans.
The Latest on: On-demand vaccines
via Google News
The Latest on: On-demand vaccines
- Vaccines for kids, so far so goodon April 22, 2021 at 5:30 pm
Private Hospitals and Nursing Homes’ Association (PHANA) president Dr HM Prasanna said, “It is too early to comment. However, we don’t want to go via government channels as it is an erratic process.
- Here's what you really need to get a COVID vaccine in Ontarioon April 22, 2021 at 12:54 pm
An alchemy involving copious free time, a car and loads of social capital—adding up to a terrible way to get jabs into the arms that need them most ...
- Membrane Vesicles Unlock Potential for Freeze Dried Cell-Free Expression Tech to Mass Produce Vaccines On Siteon April 22, 2021 at 5:00 am
Developers say optimized, shelf-stable cell-free tech could enable single 1,000 liter reactor to produce 40M vaccine doses/day at $1 per dose.
- Penn State Schuylkill to hold vaccine clinic for alumni, family, friendson April 22, 2021 at 3:33 am
Penn State Schuylkill will hold a COVID-19 vaccine clinic on campus Friday in partnership with Providence Place Senior Living. Care Options Rx pharmacy will be running the Pfizer vaccination clinic, ...
- Is the COVID-19 vaccine supply outpacing demand in Arizona?on April 21, 2021 at 4:01 am
State health officials are seeing more vaccine appointments go unfilled as 38.3% of Arizonans are now vaccinated, according to the Arizona Department of Public Health. At the University of Arizona ...
- States have a new Covid problem: Too much vaccineon April 21, 2021 at 1:33 am
Millions of Americans are still getting shots each day — but, in a jarring twist after months of scarcity, too many slots remain open as skeptics hold out.
- North Dakota, Manitoba Form Trucker Vaccine Pact: Virus Updateon April 20, 2021 at 2:55 pm
Shipments of Johnson & Johnson’s Covid-19 vaccine will be restarted to the European Union after the bloc’s drug regulator said benefits of the shot outweigh the risks of a possible link to cases of ...
- All U.S. Adults Can Get the COVID Vaccine. Now What?on April 19, 2021 at 4:00 pm
The country’s vaccine rollout has hit a major milestone, but expanding access and increasing demand in the next phase won’t be easy.
- Harris County Opens 55,000 New Vaccine Slots After Unexpected Drop In Demandon April 16, 2021 at 1:18 pm
Six out of nearly 7 million people who received the Johnson & Johnson vaccine had a potentially dangerous side effect -- or roughly 0.00000088% of all patients. But officials are afraid that's led to ...
- Harris County Launches On-Demand COVID-19 Vaccine Appointment Site and Ditches Waitliston April 16, 2021 at 11:49 am
Harris County Judge Lina Hidalgo announced Friday that the county has launched a coronavirus vaccine sign-up website. Starting Friday, county residents can sign up for one of 55,000 vaccine ...
via Bing News